Artificial Intelligence In Drug Discovery and Screening Market Research Report - Segmented By Application (Drug Optimization & Repurposing, Preclinical Testing), By Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Others) By Region (North America, Europe, Asia-Pacific, Latin America, The Middle East, and Africa), And Segment Forecasts, 2024 - 2030

Chapter 1.AI Drug Discovery & Screening Market– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.AI Drug Discovery & Screening Market– Executive Summary

2.1. Market Size & Forecast – (2024 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-13 Impact Analysis

      2.3.1. Impact during 2024 - 2030

      2.3.2. Impact on Supply – Demand

Chapter 3.AI Drug Discovery & Screening Market– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.AI Drug Discovery & Screening Market - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. AI Drug Discovery & Screening Market- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6.AI Drug Discovery & Screening Market– By Application

6.1. Drug Optimization & Repurposing

6.2. Preclinical Testing

6.3. Other

Chapter 7.AI Drug Discovery & Screening Market– By Therapeutics

7.1. Oncology

7.2. Neurodegenerative Diseases

7.3. Cardiovascular Diseases

7.4. Metabolic Diseases

7.5. Infectious Diseases

7.6. Others

Chapter 8.AI Drug Discovery & Screening Market– By Region

8.1. North America

8.2. Europe

8.3. The Asia Pacific

8.4. Latin America

8.5. The Middle East

8.6. Africa

Chapter 9.AI Drug Discovery & Screening Market– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

9. 1. IBM Watson

9.2. Exscientia

9.3. GNS Healthcare

9.4. Alphabet (DeepMind),

9.5. Benevolent AI)

9.6. BioSymetrics

9.7. Euretos

9.8. Berg Health

9.8. Atomwise Intro

9.9. Cyclica

 

Download Sample

The field with (*) is required.

Choose License Type

$

2850

$

5250

$

4500

$

1800